A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder

scientific article published on 19 February 2019

A case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1112229884
P356DOI10.1186/S12888-019-2055-1
P932PMC publication ID6381751
P698PubMed publication ID30782143

P50authorAndrea GalovaQ91720096
P2093author name stringJules Desmeules
Marie Besson
Patricia Berney
Ioannis Sergentanis
P2860cites workSevere Relapsing Clozapine-Withdrawal CatatoniaQ36405646
Acetylcholine-dopamine interactions in the pathophysiology and treatment of CNS disorders.Q37725116
Catatonia Secondary to Sudden Clozapine Withdrawal: A Case with Three Repeated Episodes and a Literature ReviewQ37726344
From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychoticsQ37771644
The CARE Guidelines: Consensus-based Clinical Case Reporting Guideline DevelopmentQ38177824
Clozapine withdrawal catatonia and neuroleptic malignant syndrome: a case reportQ40645743
Clozapine withdrawal effects and receptor profiles of typical and atypical neurolepticsQ40952478
Clozapine in tardive dyskinesiaQ41370034
Clozapine withdrawal resulting in delirium with psychosis: a report of three casesQ41536197
A Case of Risperidone Overdose in a 4-Year-Old Boy.Q42408865
Extrapyramidal symptoms following accidental ingestion of risperidone in a childQ42520678
Clozapine withdrawal catatonia associated with cholinergic and serotonergic rebound hyperactivity: a case reportQ45189024
Cholinergic rebound and rapid onset psychosis following abrupt clozapine withdrawalQ46872086
The Treatment of Clozapine-Withdrawal Delirium with Electroconvulsive Therapy.Q47136916
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017.Q47621835
Controlled, double-blind investigation of the clozapine discontinuation symptoms with conversion to either olanzapine or placebo. The Collaborative Crossover Study Group.Q51981197
Withdrawal from clozapine: the "rebound phenomenon".Q51981895
Catatonia following abrupt stoppage of clozapine.Q53964235
A model of anticholinergic activity of atypical antipsychotic medicationsQ59739287
Cautions in the clozapine-to-risperidone switchQ71115876
Anticholinergics to treat clozapine withdrawalQ72152249
Clozapine-olanzapine: a potentially dangerous switch. A report of two casesQ78100895
Managing clozapine discontinuation - acute and chronic maintenance strategiesQ85300920
Clozapine Discontinuation and Malignant Catatonia: A Case ReportQ88497353
Review of withdrawal catatonia: what does this reveal about clozapine?Q90672919
Catatonia Due to Clozapine Withdrawal: A Case Report and Literature ReviewQ91879159
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)73
P577publication date2019-02-19
P1433published inBMC PsychiatryQ15750257
P1476titleA case report of cholinergic rebound syndrome following abrupt low-dose clozapine discontinuation in a patient with type I bipolar affective disorder
P478volume19

Reverse relations

cites work (P2860)
Q89804908Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database
Q96773916The report of the joint WPA/CINP workgroup on the use and usefulness of antipsychotic medication in the treatment of schizophrenia

Search more.